Market Research Report Store Skin And Soft Tissue Infections-API Insights, 2017 | Page 3

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry
details and exclusivity with respect to
Skin And Soft Tissue Infections.
• API intelligence over marketed drugs for
Skin And Soft Tissue Infections and gaining primary
intelligence over active ingredients manufacturers across the globe.
• Uncovering opportunities in the rapidly growing the US markets.
Some TOC of the Market Research Report:
• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Sales Figures (2012-2016)
• Marketed Drugs Information
• Drugs Description
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Discontinued Drugs Information
Contact:
Ann